PCDE’s latest publication

PCDE’s latest publication

Benefits and harms of sodium-glucose co-transporter-2 inhibitors (SGLT2-I) and renin–angiotensin–aldosterone system inhibitors (RAAS-I) versus SGLT2-Is alone in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.Samuel...
EUDF-EASD symposium on 29 September

EUDF-EASD symposium on 29 September

IT TAKES MORE THAN JUST A REGISTRY TO IMPROVE CARE:   HOW CAN WE USE DATA TO RAISE AWARENESS AND INITIATE ACTION TO IMPROVE OUTCOMES FOR PEOPLE WITH DIABETES? Welcome and introduction David Matthews, University of Oxford, vice-chair EUDF How can we use data to raise...